U.S. authorities subpoena GSK regarding diabetes drug Avandia

10/21/2010 | Wall Street Journal, The

GlaxoSmithKline has received a subpoena from the Justice Department and "civil investigative demands" from state authorities concerning the development and marketing of diabetes treatment Avandia. "These inquiries are at an early stage, and GSK is cooperating with these offices," the drugmaker said.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Chief Executive Officer
UCare Minnesota
Minneapolis, MN
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC